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Family Cluster of Rocky Mountain Spotted Fever 
Timothy F. Jones, Allen S. Craig, 
Christopher D. Paddock, Don B. McKechnie, 
James E. Childs, Sherif R. Zaki, and William Schaffner 
From the Epidemic Intelligence Service, Epidemiology Program Office, 
the Viral and Rickettsial Zoonoses Branch, and the Infectious Disease 
Pathology Activity, Centers for Disease Control and Prevention, Atlanta, 
Georgia; and the Tennessee Department of Health, and the Departments 
of Preventive Medicine and Medicine, Vanderbilt University School of 
Medicine, Nashville, Tennessee 
Soon after a patient from Tennessee died of Rocky Mountain spotted fever (RMSF), several 
family members developed symptoms suggestive of the disease and were treated presumptively for 
RMSF. Fifty-four persons visiting the index patient's home were interviewed; serum samples were 
collected from 35. Three additional cases of RMSF were confirmed, all of which occurred in first- 
degree relatives. Time spent at the family home and going into the surrounding woods were signifi- 
cantly associated with developing antibodies to Rickettsia rickettsii. Ticks were collected and exam- 
ined for rickettsiae by polymerase chain reaction analysis. Because hyperendemic foci and family 
clusters of RMSF can occur, when a case is suspected clinicians should be vigilant for signs and 
symptoms consistent with R. rickettsii infection in other persons who may have been similarly 
exposed. 
Indeed, one of the characteristic features of the disease . 
is the rare occurrence of more than one case in a given family 
during a season .... 
-Howard T. Ricketts, 1909 [1] 
Rocky Mountain spotted fever (RMSF) is a tick-borne dis- 
ease caused by Rickettsia rickettsii, the case-fatality ratio for 
which approaches 25% if untreated. Despite the availability of 
effective antibiotic therapy, the case-fatality ratio has remained 
at 4% to 10% since the 1950s [2-4]. The number of reported 
cases of RMSF in the United States has steadily increased over 
the past 5 years, and in 1996, cases were at their highest levels 
in over a decade [5]. Eighty-two percent of reported cases 
occurred in the South Atlantic and south central regions, with 
<2% of cases reported from the mountain states [5]. 
Although typically considered a sporadic disease, familial 
clusters of RMSF have been reported occasionally [6-11]. 
There have also been reports of foci ("islands") of disease 
hyperendemicity [12-21]. These foci have encompassed re- 
gions as large as entire counties [12, 13, 15] or areas of several 
square kilometers [12, 17, 18] and discrete geographical units 
including neighborhoods [22, 23] and urban parks [16]. The 
recognition of clustering of disease and islands of hyperendem- 
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icity is important for medical providers and public health per- 
sonnel involved in treating and controlling the disease, because 
multiple infections can occur simultaneously or following iden- 
tification of an index case. 
Case Report 
In August 1997, a previously well 49-year-old American 
Indian man from Tennessee presented to an emergency depart- 
ment in West Virginia, where he was traveling on business. 
He had a 5-day history of fever, headache, diffuse myalgias, 
and vomiting. The patient noted small red "chigger bites" 
around the ankles but recalled no recent tick bites. Physical 
examination revealed no identifiable source of infection, and 
no rash was noted. He was thought to have a viral illness and 
was discharged receiving symptomatic treatment. However, the 
symptoms increased, and 2 days later he was taken to a second 
hospital, where he presented with a temperature of 97.5?F, 
blood pressure of 112/84 mm Hg, respirations of 20/min, and 
pulse of 135/min. He appeared ill with clammy, mottled skin. 
Laboratory studies disclosed a normal WBC count of 9.4 x 
109/L, platelet count of 34 X 109/L, partial thromboplastin time 
of 42.7 seconds (normal range, 22-32 seconds), prothrombin 
time of 12.6 seconds (normal range, 11-14 seconds), and creat- 
inine level of 415 /mol/L (4.7 mg/dL). Within hours of admis- 
sion, the patient became increasingly tachypneic, developed 
seizures and ventricular fibrillation, and died. Conjunctival 
hemorrhage and lower extremity petechiae were observed at 
death. 
854 Jones et al. CID 1999;28 (April) 
An autopsy revealed pulmonary edema, mild splenic conges- 
tion, acute tubular necrosis of the kidneys, and hepatomegaly, 
but otherwise no specific cause of death was found. Approxi- 
mately 1 month after his death, PCR testing and immunohisto- 
chemical staining of tissue specimens that were performed at 
the Centers for Disease Control and Prevention (CDC) revealed 
R. rickettsii in the endothelium of organs including brain, 
spleen, liver, kidneys, heart, and lung. The Tennessee State 
Health Department was notified, precipitating an investigation. 
Although the patient lived in a primarily urban county, his 
home was on a heavily wooded lot in a semirural area. In the 
days preceding his funeral and before discovery of the cause 
of death, friends and relatives from eight states congregated at 
his home. Many of these individuals participated in a 72-hour 
American Indian ceremonial fire on the patient's property. The 
day after the funeral, the index patient's wife was admitted to 
the hospital and diagnosed with RMSF. Several other friends 
and family members subsequently developed symptoms com- 
patible with the disease and were treated presumptively for 
RMSF. 
Methods 
A questionnaire was administered to persons reported to 
have spent time at the patient's home during the week between 
his death and the time of his funeral. Information was collected 
on demographic variables, symptoms, treatment, and medical 
history. Questions were asked about participation in the cere- 
monial fire, eating or smoking outdoors, going into the woods, 
tick exposure, repellent use, and other activities and behaviors 
potentially related to the risk of contracting RMSF. 
Serum samples were obtained from consenting participants, 
and these specimens were tested for IgG antibodies to R. ricket- 
tsii by an indirect immunofluorescence assay (IFA) at the CDC 
[24]. Initial serum specimens were obtained 6-10 weeks after 
the index patient's funeral. Patients with positive antibody titers 
were asked for a second serum specimen 4-6 weeks later. 
Pathological specimens were tested for the presence of spotted- 
fever group (SFG) rickettsiae by using immunohistochemical 
staining [25] and PCR analysis. PCR products were sequenced 
and compared with known genetic sequences of rickett- 
siae [26]. 
A confirmed case of RMSF was defined as a clinically com- 
patible illness (fever, headache, myalgia, or rash within 3 weeks 
of exposure) accompanied by a fourfold or greater change in 
the titer of antibody to R. rickettsii that was revealed by IFA 
testing of two separate serum specimens or by demonstration of 
SFG rickettsiae in a tissue specimen by immunohistochemical 
staining [27]. 
Ticks were collected from the index patient's home property 
and five similar control sites in the vicinity over a period of 2 
successive days, 35 days after his funeral. The control sites 
included adjacent and nearby homes and properties within 3 
miles that had similar vegetation, geography, pet ownership, 
and apparent use patterns. Flannel flags (1 m2) were dragged 
over low vegetation in wooded and grassy areas and the edges 
of driveways, roads, paths, and dwellings and were examined 
for ticks approximately every 10 m. Ten CO2 traps were also 
placed near the index patient's home at 10-m intervals along 
the perimeter of the yard for 6 hours. Ticks were identified 
and tested at the CDC for the presence of the rickettsial 17- 
kDa gene by PCR analysis according to a modification of 
previously reported techniques [28] (D. B. McKechnie, J. Hat- 
field, J. W. Sumner, C. D. Paddock, J. Olson, and R. F. Mas- 
sung, unpublished data). 
Statistical analyses were performed by X2 and Fisher's exact 
tests with use of Epi Info software [29]. 
Results 
In addition to the index case, three confirmed cases of RMSF 
occurred after the funeral (table 1). Following the death of the 
index patient and before recognition of the cause of his death, 
his wife was the first person diagnosed with RMSF. The wife 
and brother of the index patient were both hospitalized because 
of severe febrile exanthematous illnesses within 2 weeks of 
the funeral. Both patients had a fourfold or greater rise in 
the titer of antibody to R. rickettsii. The index patient's sister 
developed a milder illness 2 weeks after the funeral and was 
treated successfully as an outpatient. A fourth seropositive indi- 
vidual, the son of the index patient, had evidence of antibody 
to R. rickettsii at a titer of 1:64, which persisted unchanged 
when retested 10 weeks later. He developed conjunctivitis and 
mild headache beginning 2 days after the funeral; his symptoms 
resolved without antibiotic therapy. 
The investigation also identified another family member, a 13- 
month-old grandnephew of the index patient, who had died of 
RMSF 27 months before the index patient's funeral (table 1). The 
child had been living with the index patient's sister, ~5 miles 
from the index patient's home. He had spent time at the index 
patient's home before his death, although the family was unable 
to quantify this period and could recall no tick bites. Immunohisto- 
chemical staining of a tissue specimen that was obtained at autopsy 
of the child demonstrated SFG rickettsiae. 
Fifty-five persons were identified as visitors or residents of 
the index patient's home during the week of his funeral. All 
but one (98%) of these persons-37 (67%) of whom lived in 
one of eight states outside of Tennessee-responded to the 
questionnaire. Thirty-five persons (65%) provided one or more 
serum specimens for testing; of these persons, 13 (37%) lived 
in Tennessee, and 22 (63%) lived in other states. After the 
wife's diagnosis, other family members were notified and urged 
to seek medical attention. Sixteen family members and friends 
of the index patient, all of whom spent time at his home during 
the week before his funeral, received doxycycline to either treat 
or avert RMSF. Fourteen of these persons were among those 
submitting serum specimens. Aside from the index patient's 
wife, brother, sister, and son who were mentioned above, none 
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Table 1. Clinical characteristics of five patients associated with a cluster of cases of RMSF confirmed by serological testing or immunohisto- 
chemical analysis. 
Serum IFA titer 
Relationship 
Age to index Predominant signs or First Second Third Antibiotic 
(y)/sex patient Date of onset symptoms sample sample sample therapy Outcome 
49/M Index 15 August 1997 Fever, headache, NA NA NA None Died; Rickettsia rickettsii 
myalgias, vomiting identified at autopsy by 
immunohistochemical 
analysis and PCR testing 
50/F Wife 26 August 1997 Fever, headache, <1:40* 1:160* 1:1,024 Doxycycline Well after 4-d 
myalgias, rash hospitalization 
56/M Brother 8 September 1997 Headache, falling, rash, <1:64* >1:512* 1:2,048 Doxycycline Well after 12-d 
hyponatremia, hospitalization 
thrombocytopenia 
52/F Sister 11 September 1997 Headache, myalgias, 1:128 1:32 NA Doxycycline Resolved with outpatient 
upper respiratory treatment 
tract symptoms, 
cough 
1/M Grandnephew 11 May 1995 Rash, fever, vomiting, <1:64* NA NA Chloramphenicol Died 27 mo before index 
diarrhea patient's funeral; 




NOTE. IFA = indirect immunofluorescent antibody; NA = not available; RMSF = Rocky Mountain spotted fever. 
* Serum samples tested at laboratories other than the CDC. 
of these persons had titers of antibody to R. rickettsii at or 
above the cutoff titer of 1:64. 
When funeral attendees with titers of antibody to R. rickettsii 
of 1:64 were compared with those with titers of <1:64, the 
presence of antibodies was associated with greater time spent at 
the family home during the week of the funeral, going into the 
woods surrounding the home, and being a first-degree relative of 
the index patient. Three of the five persons with evidence of 
recent or past infection with R. rickettsii resided at the index 
patient's home before his death. The ceremonial fire was attended 
by numerous persons for varying lengths of time, but the presence 
of antibodies to R. rickettsii was not correlated with length of 
time at the fire, collecting firewood, sitting on the ground, doing 
yard work, eating or smoking outside, not using insect repellents, 
noting a tick on one's body, or contact with the index patient's 
pet dog (who had not recently been ill). 
Six hours of dragging flags yielded 133 ticks from the index 
patient's home property. In 12.5 hours of dragging flags at five 
control sites, only three ticks were collected. All ticks collected 
were identified as Amblyomma americanum (Lone Star tick) 
nymphs, except for one adult tick of the same species and a 
single Haemaphysalis leporispalustris (rabbit tick). PCR test- 
ing revealed the rickettsial 17-kDa gene in 10 of 11 pools of 
ticks (each pool contained -13 ticks). Gene sequencing of 
the PCR products showed that the ticks harbored Rickettsia 
amblyommii, a newly recognized Rickettsia species [30] not 
known to be pathogenic for humans. 
Discussion 
These data document a cluster of RMSF that occurred in a 
single family and suggest that the focus of R. rickettsii had 
persisted in the same location or vicinity for at least 2 years. 
Although RMSF is generally sporadic, family clusters of dis- 
ease have been recognized for >90 years [6-11, 20, 22, 31- 
63] (table 2). In some series, as many as 4% to 8% of all 
Table 2. Previously reported family clusters of RMSF. 
No. of 
family No. of 
members clusters 
Year(s) State(s) in cluster reported [Reference(s)] 
1904-1987 AL, IA, IL, MD, 2 51 [6-8, 10, 20, 
MO, MS, MT, 22, 31-61] 
NC, NJ, NY, 
OH, RI, SC, 
TN, TX, VA, 
WV, WY, 
Mexico 
1905-1973 IA, MS, MT, 3 9 [6, 9, 11, 32, 
NC, WV, 34, 43, 62] 
Mexico 
1931 LA 4 1 [20] 
1942 OK 6 1 [20, 63] 
NOTE. RMSF = Rocky Mountain spotted fever. 
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Table 3. Reported geographic foci of RMSF in the United States. 
No. of 
Location Period cases* Nature of focus [Reference(s)] 
Wyoming 1895-1915 NS Cases clustered in two central counties [33] 
Idaho 1914 386 Most cases clustered in six southern counties [33] 
Bitterroot Valley, Montana 1900-1980 400 Valley about 75 miles long [32] 
Cape Cod, Massachusetts 1955-1968 30 Cases concentrated in four areas on Cape Code and offshore islands [12, 18] 
Long Island, New York 1961-1988 59 Rate in East Hampton, Suffolk County, greater than that in other towns in [64] 
area (overlaps with focus below) 
Long Island, New York 1971-1976 124 80% of cases in New York during 1941-1970 occurred in Suffolk [21, 64] 
County; concentrated 2.2 km from shoreline 
Clermont County, Ohio 1962-1971 85 94-km2 area in a suburbanizing county [13] 
Columbus, Ohio 1966-1981 28 28 cases in Franklin County occurred within 2 miles of this 0.11-km2 [23] 
(275-acre) area 
Ohio 1981 S Clermont, Franklin, and Lucas Counties (overlaps with two foci above) [47, 65] 
Virginia 1969 NS Six counties in Piedmont plateau area with highest incidence [66] 
North Carolina 1970-1979 12 0.5-mile stretch of road in a small town in North Carolina, 12 cases in 40 [22] 
households over 10 y 
Alabama 1973 12 "Highly endemic spotted fever area in northwest Alabama" [67] 
Missouri 1974-1984 71 35% of cases in the state occurred in three counties [68] 
Mississippi 1975-1979 NS Two-thirds of cases occurred in 14 contiguous counties in the north and [69] 
northeast part of the state 
North Carolina 1979-1981 NS Cabarrus and Rowan Counties; rate of RMSF four times that in North [15, 70] 
Carolina and 30 times that in the U.S. 
Texas 1979-1988 NS Nine counties in north central Texas reporting >10 cases [71] 
Tarrant County, Texas 1983 8 6.4 X 9.6-km area where eight cases occurred in 2 mo [17] 
Oklahoma 1981-1985 NS Cases concentrated in 10 central counties [72] 
South Carolina 1985-1990 NS Four counties with increased incidence [73] 
New York City 1987 4 Near Soundview Park, Bronx [16] 
Delaware 1996 4 Children at summer camp [74] 
NOTE. NS = not specified; RMSF = Rocky Mountain spotted fever. 
patients with RMSF were part of family clusters [2, 22]. Simi- 
larly, the concepts of islands or foci of disease hyperendemicity 
have been noted previously (table 3) [12-23, 32, 33, 47, 64- 
74]. Such foci have included areas of several square kilometers 
with persistently high rates of disease over periods of several 
years and rarely family members acquiring disease simultane- 
ously. Our cluster apparently occurred from exposure around 
a single home. 
The reasons for focal clustering of RMSF could include 
variable distribution of tick populations, focal areas of in- 
creased tick infection with R. rickettsii, increased rickettsial 
virulence or host susceptibility, new incursions of humans into 
tick-infested areas, or a combination of these factors. The po- 
tential of dogs as a possible reservoir of R. rickettsii s debated 
[75], and in this study, direct contact with the family dog was 
not correlated with disease. R. rickettsii s passed transovarially 
from adult females to their progeny; therefore, foci may be 
expected to occur. Several studies have estimated that - 1% 
of ticks may carry pathogenic R. rickettsii even in areas of 
endemicity [65, 76]. Although some studies have not found 
differences in distribution of infected ticks related to rates of 
disease [12, 13, 77-79], other investigators have noted a corre- 
lation [16, 21, 65]. 
In the eastern United States, the primary vector of R. rickett- 
sii is Dermacentor variabilis (American dog or wood tick) [4]. 
Whether the Lone Star tick A. americanum also transmits the 
disease is debated [3, 4, 67]. Many of the people interviewed 
in this study described large numbers of small, pinpoint-sized 
brown "seed ticks" at the home and on their bodies, and 
other persons denied tick bites but noted numerous itchy red 
"chigger bites" around the ankles. Seed ticks are the small, 
six-legged larval stage of hard ticks, including A. americanum, 
and these ticks can be difficult to see and identify. Some reports 
suggest that larval A. americanum ticks are capable of biting 
humans and transmitting R. rickettsii [80], which may account 
for some cases of RMSF without a recognized history of tick 
bite [81]. 
Only A. americanum ticks were collected from the index 
patient's property in this study, although collection did not 
occur until 5 weeks after his death. Possibly, the tick population 
had changed in the 5-week interval between his death and 
collection, and D. variabilis was the vector in this cluster but 
was not present at the time of collection. The patient's property 
was heavily wooded, with habitat that would support popula- 
tions of both species. No obvious factors were apparent to 
account for the clustering of ticks at the index site, compared 
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with the remarkably lower rate of tick collection from adjacent 
properties. 
This investigation used PCR analysis and gene sequencing 
to identify rickettsiae; R. amblyommii was found, but there was 
no evidence of R. rickettsii. The PCR technique amplified and 
allowed specific identification of DNA from the predominant 
rickettsial species in the tick pools. The sensitivity of the tech- 
nique is not known. Possibly, lower levels of R. rickettsii were 
present in this tick population but went undetected by this 
method. 
Only seven of the 16 persons in this investigation who were 
treated empirically for RMSF had any type of rash. Previous 
studies of RMSF suggest that the characteristic rash may be 
absent in 5% to 34% of patients [2-4, 64, 82] and that only 
one-half may have a rash within the first 3 days [82]. Lack of 
a rapid diagnostic test for RMSF necessitates treatment based 
on the history and results of physical examination plus a high 
index of suspicion. Only three (21%) of the 14 symptomatic 
persons treated presumptively from whom serum samples were 
available had antibodies to R. rickettsii at titers of >1:64. It 
has been reported that treatment with antibiotics within the 
first few days of disease onset may blunt the development of 
antibodies detectable by CF and microagglutination testing 
[83-86] but that other tests are less affected [85]. This phenom- 
enon has not been extensively studied with the IFA test. 
One person who provided serum samples but was not treated 
for RMSF had a titer of IgG antibody to R. rickettsii of 1:64, 
which was unchanged when tested again 10 weeks later. He 
often worked in the woods near the family home and had a 
long history of frequent tick bites; however, he had never been 
diagnosed with RMSF and could not recall a specific illness 
suggestive of the disease. This case may represent a stable, 
persistent antibody titer from a previous asymptomatic or un- 
recognized infection with R. rickettsii or possibly another SFG 
Rickettsia. Serosurveys have revealed detectable titers of anti- 
body to SFG rickettsiae in 11% to 21% of sixth graders [17, 87] 
and 29% of adults in areas of endemicity [70]. The existence of 
asymptomatic infections is debated [4], although the lack of 
specificity of symptoms makes unrecognized mild infections 
likely. 
This cluster is a salient example of the importance of consid- 
ering RMSF in the differential diagnosis of patients with febrile 
illnesses who present in the spring and summer in areas of 
endemicity. Prophylactic treatment of asymptomatic persons 
exposed to ticks is not recommended [88, 89], even in areas 
where RMSF is endemic. However, because of a lack of spe- 
cific symptoms or a rapid diagnostic test, empirical treatment 
of persons with suspected cases is often necessary. Although 
Ricketts [1] long ago noted their "rare occurrence," family 
clusters and hyperendemic foci of RMSF may be more common 
than appreciated. When a case of RMSF is suspected, it is 
important for family members and physicians to remain vigilant 
for signs or symptoms consistent with R. rickettsii infection in 
other persons who may have been similarly exposed. 
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